ArticleFrontiers in microbiology2026
When less is more: cell size reduction as a metabolic lifeline in
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: How living cells regulate their function and adapt to stress remains a fundamental question in cell biology. In bacteria, stress responses are classically described at the genomic and transcriptomic levels; however, this paradigm does not adequately explain adaptation in mycoplasmas, which are widely regarded as a model of a minimal cell. Methods: This study investigated stress adaptation in mycoplasmas by analyzing cellular volume and morphology changes by SEM, DLS, and EPR. Membrane lipid composition was analyzed by mass spectrometry. Intracellular ATP levels were measured using a luciferase‑based assay. Vesicles were isolated by ultracentrifugation and characterized by proteomics, enzyme activity assays, and ATP measurements. Glycolytic flux was assessed in vitro using recombinant enzymes and liposome encapsulation. Results: Stress adaptation in this minimal cell is primarily achieved through a reduction in cellular volume, mediated by the release of the attachment organelle ("tip") in the form of vesicles. This process triggers metabolic reorganization within the cell and results in the accumulation of ATP. The metabolic adaptation involves changes in the stoichiometric balance of glycolytic enzymes and alterations in local metabolite concentrations under conditions of reduced cell volume, both of which directly influence glycolytic flux. Concurrently, the released vesicles contain VlhA, lipoproteins, adhesins, hydrogen-peroxide-secreting factors, and exhibit peptidase activity. Discussion: These findings reveal a novel regulatory mechanism in a minimal cell, where physical volume reduction and biochemical adjustments may be related to an energy-efficient stress response. The dual role of vesicle formation-in cellular remodeling and pathogenesis-deepens our understanding of mycoplasma biology and offers insights for synthetic cell design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.